The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Shanghai Jiaotong Releases 2011 Academic Rankings: US Colleges Dominate
US colleges dominated the 2011 ranking of world universities released by Shanghai's Jiaotong University today, with Harvard topping the list for the ninth year in a row.
Japan Loans Pakistan US$65 Million For Polio Eradication
The Japan International Cooperation Agency (JICA) will provide up to US$65 million to Pakistan as part of a loan agreement towards polio eradication.
Diarrhea-Causing Enterotoxin Receptor May Be Linked To ADHD
Chinese scientists have discovered that ADHD and other neuropsychiatric disorders may be caused by the abnormal function of a diarrhea-causing enterotoxin receptor.
Dr. Rossa Chiu, Chinese Uni. Of Hong Kong, Talks To Asian Scientist Magazine
We speak with CUHK's Prof. Rossa Chiu Wai Kwun, a doctor who has developed a safer, non-invasive technique for fetal genetic testing.
China Releases 600 Million Bees To Control American White Moth Population
China's State Forestry Administration has released 600 million bees (周氏啮小蜂) in the northern city of Baoding to kill off American white moths, which have plagued large areas of crops and forests.
ADB Loans Indonesia US$100 Million For Sanitation & Infrastructure Projects
The Asian Development Bank will lend Indonesia US$100 million to finance basic infrastructure projects in rural villages.
Folate Intake May Lower Breast Cancer Risk In Premenopausal Women
A US-China joint study has shown that folate intake reduces the risk of breast cancer in premenopausal women by 40 percent.
Kyowa Kirin Starts Phase III Trial Of ARQ197/Erlotinib In NSC Lung Cancer
Kyowa Hakko Kirin is starting a Phase III trial evaluating the combination of ARQ 197 (tivantinib) and erlotinib in Asia for patients with advanced or metastatic non-small cell lung cancer.
Older New Zealanders Underestimate Their Risk Of Deadly Skin Cancer
New Zealanders aged 60 and over falsely believe they are at low risk of the fatal skin cancer melanoma, according to a new study.